Trial intelligence / Profile preview

Effect of carbamazepine on hearing and pitch perception

NL-OMON40099Active, not recruiting

Sponsor
University Medical Center Groningen
Start
Sep 2014
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of carbamazepine, sponsored by University Medical Center Groningen. Primary endpoint: Shift of spontaneous otoacoustic emission frequencies related to carbamazepine use. Started Sep 2014; status: active, not recruiting.

02

Drugs

carbamazepine

Beyond the preview

Go deeper on NL-OMON40099.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON40099.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call